On Thursday, August 22, 2019 from 1:00pm to 2:30pm EST, the FDA will hold a webinar to provide additional information on this final guidance document and provide participants an opportunity to have questions answered by subject matter experts on this topic.
On June 27, 2019, the U.S. Food and Drug Administration (FDA) issued the Marketing Clearance of Diagnostic Ultrasound Systems and Transducers final guidance. This final guidance provides recommendations for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers. The guidance covers key aspects of ultrasound safety to continue to promote the safe use of ultrasonic imaging.
